92 results on '"Davies, Kay E."'
Search Results
2. Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial.
3. Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophy
4. Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophy
5. Alterations of neuromuscular junctions in Duchenne muscular dystrophy
6. Synthesis of SMT022357 enantiomers and in vivo evaluation in a Duchenne muscular dystrophy mouse model
7. Limitations to adaptive homeostasis in an hyperoxia-induced model of accelerated ageing
8. Micro-dystrophin Genes Bring Hope of an Effective Therapy for Duchenne Muscular Dystrophy
9. Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx Mice
10. Pharmacological advances for treatment in Duchenne muscular dystrophy
11. The antioxidant protein Oxr1 influences aspects of mitochondrial morphology
12. 2015 William Allan Award 1
13. The Evolutionarily Conserved Tre2/Bub2/Cdc16 (TBC), Lysin Motif (LysM), Domain Catalytic (TLDc) Domain Is Neuroprotective against Oxidative Stress
14. Circadian profiling in two mouse models of lysosomal storage disorders; Niemann Pick type-C and Sandhoff disease
15. A Novel Mouse Model of a Patient Mucolipidosis II Mutation Recapitulates Disease Pathology
16. Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice
17. Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse
18. AAV Genome Loss From Dystrophic Mouse Muscles During AAV-U7 snRNA-mediated Exon-skipping Therapy
19. Translating the Genomics Revolution: The Need for an International Gene Therapy Consortium for Monogenic Diseases
20. Spinal muscular atrophy at the crossroads of basic science and therapy
21. Engineering Multiple U7snRNA Constructs to Induce Single and Multiexon-skipping for Duchenne Muscular Dystrophy
22. Disrupted Circadian Rhythms in a Mouse Model of Schizophrenia
23. The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense Delivery
24. Current Status of Pharmaceutical and Genetic Therapeutic Approaches to Treat DMD
25. Prevention of Dystrophic Pathology in Severely Affected Dystrophin/Utrophin-deficient Mice by Morpholino-oligomer-mediated Exon-skipping
26. Enhanced Exon-skipping Induced by U7 snRNA Carrying a Splicing Silencer Sequence: Promising Tool for DMD Therapy
27. Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model
28. Syncoilin isoform organization and differential expression in murine striated muscle
29. Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: An MRI and MRS study
30. Activation of mutant protein kinase Cγ leads to aberrant sequestration and impairment of its cellular function
31. Is Good Housekeeping the Key to Motor Neuron Survival?
32. Microarray analysis of mdx mice expressing high levels of utrophin: Therapeutic implications for dystrophin deficiency
33. Generation and Characterization of Transgenic Mice with the Full-length Human DMD Gene
34. Intermediate filament-like protein syncoilin in normal and myopathic striated muscle
35. High-Throughput Analysis of Promoter Occupancy Reveals Direct Neural Targets of FOXP2, a Gene Mutated in Speech and Language Disorders
36. Modified Patient Stem Cells as Prelude to Autologous Treatment of Muscular Dystrophy
37. Behavioural characterisation of the robotic mouse mutant
38. The allure of stem cell therapy for muscular dystrophy
39. Mutations in α-Tubulin Cause Abnormal Neuronal Migration in Mice and Lissencephaly in Humans
40. Treating Muscular Dystrophy with Stem Cells?
41. Gene expression profiling studies on Caenorhabditis elegans dystrophin mutants dys-1(cx-35) and dys-1(cx18)
42. Identification and Characterization of Murine SCARA5, a Novel Class A Scavenger Receptor That Is Expressed by Populations of Epithelial Cells
43. Isolation and culture of motor neurons from the newborn mouse spinal cord
44. A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration
45. Syncoilin accumulation in two patients with desmin-related myopathy
46. A- and B-utrophin Have Different Expression Patterns and Are Differentially Up-regulated in mdx Muscle
47. The role of utrophin in the potential therapy of Duchenne muscular dystrophy
48. Identification of a New Pmp22 Mouse Mutant and Trafficking Analysis of a Pmp22 Allelic Series Suggesting That Protein Aggregates May Be Protective in Pmp22-Associated Peripheral Neuropathy
49. Association of Syncoilin and Desmin
50. Muscular Dystrophy—Reason for Optimism?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.